Spyre Therapeutics
SYRE
SYRE
84 hedge funds and large institutions have $328M invested in Spyre Therapeutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 92 → 84 (-8)
28% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 32
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
84
Holding in Top 10
3
Calls
$340K
Puts
$119K
Top Buyers
| 1 | +$5.56M | |
| 2 | +$4.82M | |
| 3 | +$3.98M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
| 5 |
SCM
Sio Capital Management
New York
|
+$1.68M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$2.08M | |
| 3 | -$1.91M | |
| 4 |
Millennium Management
New York
|
-$697K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$447K |